GE HealthCare Technologies Inc

GE Healthcare Technologies, Inc. operates as a holding company with interest in providing medical technology, pharmaceutical diagnostics and digital solutions. Its operating segments include Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded on May 16, 2022 and is headquartered in Chicago, IL.

Earnings data Q2 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

GE Healthcare Technologies, Inc. operates as a holding company with interest in providing medical technology, pharmaceutical diagnostics and digital solutions. It operates through the following segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded on May 16, 2022 and is headquartered in Chicago, IL.

GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q4 2022 Earnings Conference Call January 30, 2023 8:00 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer Peter Arduini - President and Chief Executive Officer Helmut Zodl - Vice President and Chief Financial Officer Conference Call Participants Drew Ranieri - Morgan Stanley Ed Ridley-Day - Redburn Vijay Kumar - Evercore Lawrence Biegelsen - Wells Fargo Veronika Dubajova - Citigroup Anthony Petrone - Mizuho Ryan Zimmerman - BTIG Jason Bednar - Piper Sandler Yuan Zhi - B. Riley Operator Good day, ladies and gentlemen, and welcome to the GE HealthCare Fourth Quarter 2022 Earnings Conference Call.

GE HealthCare Technologies Inc. (GEHC) Q4 2022 Earnings Call Transcript

General Electric (NYSE: GE) completed the spinoff of GE Healthcare Technologies, Inc (NASDAQ: GEHC) in December 2022, and the first earrings report is in. The news affirms the company's decision to split into 3 companies as it is a path to unlocking shareholder value.

GE Healthcare Technology: Speculating On Dividends

The company was spun out of General Electric on Jan 3. It posted fourth-quarter earnings per share of $1.31 and sales of just more than $4.9 billion.

GE HealthCare's First Solo Earnings Were Strong

The company was spun out of General Electric on Jan 3. It posted fourth-quarter earnings per share of $1.31 and operating income of $844 million from sales of just more than $4.9 billion.

GE HealthCare's First Solo Earnings Are Strong. It's Bullish on the Future.

Shares of GE HealthCare GEHC, slipped 0.1% in premarket trading Monday, after the medical technology and pharmaceutical diagnostics company reported its first results as a public company, with fourth-quarter profit falling from a year ago while revenue rose. The company, which completed its spinoff from General Electric Co. GE, +2.58% on Jan. 3, said net income slipped 1.8% to $554 million, as earning per share from continuing operations fell to $1.21 from $1.24.

GE HealthCare reports first results after GE spinoff, with revenue rising 8% but profit slipping

CHICAGO--( BUSINESS WIRE )--GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, today reported financial results for the fourth quarter and full year ended December 31, 2022.

GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results

This healthcare giant has plenty of earnings growth potential and trades at an attractive valuation.

Buy This Exceptional Stock Before Wall Street Finds Out

Alliance Resource Partners

Li-Cycle Holdings Corp

SoFi Technologies

In early trading Thursday, the Dow Jones industrials were up 0.35%, the S&P 500 was up 0.65% and the Nasdaq was up 1.16%.

Earnings Previews: Alliance Resource Partners, GE Healthcare, Li-Cycle, SoFi Technologies

CHICAGO--( BUSINESS WIRE )--GE HealthCare (Nasdaq: GEHC) and Sound Technologies, the global veterinary imaging leader, today announced an agreement to distribute the Vscan Air™, a cutting-edge, wireless pocket-sized ultrasound that provides crystal clear image quality, whole-patient scanning capabilities, and intuitive software – to veterinary practices in the United States.

Sound Technologies and GE HealthCare Announce Collaboration to Bring Vscan Air Handheld Ultrasound to Veterinary Practices Across the United States

Investors could be better off if GE HealthCare uses its cash for other purposes.

Will GE HealthCare Stock Pay a Dividend Anytime Soon?

Cost-saving multi-year agreement to provide innovative technology, help improve patient outcomes, and enhance staff wellbeing Cost-saving multi-year agreement to provide innovative technology, help improve patient outcomes, and enhance staff wellbeing

GE HealthCare and Windsor Regional Hospital Enter Long-Term Innovative Technology Agreement

Apple

An undervalued spinoff, a company continuing to transform its margin potential, and a technology giant growing its services revenue make up a list of stocks smart investors are looking at.

Dow Jones Bear Market: The Smartest Investors Are Buying These Beaten Down Stocks

D.R. Horton

General Electric

Halliburton

Lockheed Martin

Raytheon Technologies

Shortly after Friday's opening bell, the Dow Jones industrial average traded down 0.15%, while the S&P 500 traded up 0.25% and the Nasdaq Composite was up 0.77%.

Earnings Preview: DR Horton, General Electric, Halliburton, Lockheed Martin, Raytheon

Amazon

Equinix

Palo Alto Networks

Last year was terrible for some of the best cloud computing stocks, and for the Cloud Czars whose cash flow built it. Apple (NASDAQ: AAPL ), Microsoft (NASDAQ: MSFT ), Alphabet (NASDAQ: GOOGL , GOOG ), Amazon.Com (NASDAQ: AMZN ), and Meta Platforms (NASDAQ: META ) combined to lose trillions of dollars in market cap.

The 5 Best Cloud Computing Stocks to Buy for 2023

The newly minted stock has its positives and negatives.

Is GE HealthCare Stock a Screaming Buy After Its Spinoff?

CHICAGO--( BUSINESS WIRE )--GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will announce its fourth quarter and full year 2022 financial results before the market opens on Monday, January 30, 2023. The GE HealthCare management team will also host a conference call and webcast at 8:00 a.m. Eastern Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay will also all be posted at the same link on the GE HealthCare Investor Relations website.

GE HealthCare to Announce Fourth Quarter and Full Year 2022 Results on January 30, 2023

Is the new healthcare stock a buy for 2023?

Own GE HealthCare Stock? Here's What You Need to Know About the Spin-Off

GE HealthCare Technologies' shares rose on Wednesday after the company issued preliminary results for the fourth quarter and forecast continued organic revenue growth in the year ahead. The company, which completed its spin-off from General Electric (NYSE:GE) last week, said it expects 2023 organic revenue to grow by 5% to 7% from 2022 levels.

GE HealthCare Technologies jumps 8% as it forecasts continued revenue growth in 2023

The market liked what it heard from the GE spinoff's preliminary results release.

Why GE HealthCare Technologies Surged Higher Today

Ge Healthcare Technologies Inc. GEHC, -1.44% , the unit recently spun out of General Electric Co. GE, +1.01% , said Tuesday it expects fourth-quarter revenue to come to about $4.9 billion and for full-year revenue to total $18.3 billion. There are currently no FactSet consensus numbers for the new public company.

GE Healthcare sees Q4 revenue of about $4.9 billion

CHICAGO--( BUSINESS WIRE )--GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, today announced preliminary unaudited revenue results for the fourth quarter and full year 2022. The Company also issued Organic revenue growth*, Adjusted EBIT margin*, and Free cash flow conversion* guidance for 2023. President and Chief Executive Officer Peter Arduini and Chief Financial Officer Helmut Zodl will comment on these results at the 41st Annual J.P. Morgan Healthcare Conference today in San Francisco.

GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook

GE HealthCare Technologies Inc. GEHC, -1.44% late Monday said it has agreed to buy French tomography company IMACTIS for an undisclosed amount. IMACTIS's system is designed to increase the procedure's accuracy while helping reduce procedure time and radiation doses for patients and doctors, GE HealthCare said.

GE HealthCare, in first deal after spinoff, set to buy French company

CHICAGO--( BUSINESS WIRE )--GE HealthCare (Nasdaq: GEHC) today announced it has entered into an agreement to acquire IMACTIS, an innovator in the rapidly growing field of computed tomography (CT) interventional guidance across an array of care areas. IMACTIS is a France-based company that was founded in 2009 by Stephane Lavallee and Lionel Carrat, who created CT-Navigation™, an ergonomic universal solution that provides stereotactic needle guidance, enabling intuitive pre-planning and continuous control throughout a wide range of procedures, from diagnosis to treatment.

GE HealthCare Announces Agreement to Acquire IMACTIS to Strengthen Capabilities in Interventional Guidance

GE completed its long-awaited healthcare business spin-off last week. This gets the company closer to its long-term plan to split up into three focused companies across power, health, and aviation.

GE Spins Off HealthCare: What Happens Next

General Electric Co ( GE , Financial) separated its health care technology business on Jan 4, 2023, and the stock of the stand-alone company began trading on the Nasdaq under the name GE Healthcare Technologies Inc. ( GEHC , Financial). The spin-off was executed as a tax-free transaction with every three GE shares spinning out one GE Healthcare Technologie share.

News for GE HealthCare Technologies Inc Stock (GEHC)